Clinical Laserthermia Systems AB (publ)
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CLS-B.ST research report →
Companywww.clinicallaser.se
Clinical Laserthermia Systems AB (publ) develops treatment tools for diseased tissue under the TRANBERG brand in Sweden. The company offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. It also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers provides multiple options to control treatment.
- CEO
- Dan Johansson Mogren
- IPO
- 2009
- Employees
- 17
- HQ
- Lund, SE
Price Chart
Valuation
- Market Cap
- $114.21M
- P/E
- -4.08
- P/S
- 8.01
- P/B
- 2.26
- EV/EBITDA
- -3.14
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -88.29%
- Op Margin
- -215.33%
- Net Margin
- -236.57%
- ROE
- -52.48%
- ROIC
- -53.41%
Growth & Income
- Revenue
- $17.49M · -6.90%
- Net Income
- $-41,612,000 · 12.62%
- EPS
- $-1.61 · 62.82%
- Op Income
- $-28,995,000
- FCF YoY
- 39.06%
Performance & Tape
- 52W High
- $13.36
- 52W Low
- $2.60
- 50D MA
- $4.55
- 200D MA
- $6.86
- Beta
- 0.01
- Avg Volume
- 114.37K
Get TickerSpark's AI analysis on CLS-B.ST
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our CLS-B.ST Coverage
We haven't published any research on CLS-B.ST yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CLS-B.ST Report →